1. R. G. Glushkov, S. P. Golitsyn, E. V. Dorodnikova, et al., Vestn. Ross. Akad. Med. Nauk, No. 11, 38–42 (1998).
2. R. G. Glushkov, M. D. Mashkovski, and S. D. Yuzhakov, Drugs Future, 22, 30–33 (1997).
3. R. G. Glushkov, S. D. Yuzhakov, A. I. L?vov, et al., Khim.-farm. Zh., 45(2), 3–12 (2011).
4. R. G. Glushkov and A. I. L’vov, RF Pat. No. 2059612, “Method for preparing 1-phenyl-(1-p-nitrobenzoylamino)-5-N,N-diethylaminopentane and 1-phenyl-1-amino-5-N,N-diethylaminopentane hydrochloride”; Byull. Izobret., No. 13 (1996).
5. M. D. Mashkovski, R. G. Glushkov, S. Ya. Skachilova, et al., SU Pat. No. 1833612, “1-Phenyl-1-(p-nitrobenzoylamino)-5-N-piperidino)- or (N,N-diethylamino)pentane hydrochlorides exhibiting anti-arrhythmic and antifibrillatory activity” (1987).